Neurological Response to cART vs. cART plus integrase inhibitor and ccr5 antagonist initiated during acute HIV

Authors
Publication date
10 November 2015
Publisher
eScholarship, University of California

Abstract

Objective To compare central nervous system (CNS) outcomes in participants treated during acute HIV infection with standard combination antiretroviral therapy (cART) vs. cART plus integrase inhibitor and CCR5 antagonist (cART+). Design 24-week randomized

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Sustaining member

    eScholarship - University of California

    redirect
    oaioai:escholarship.org:ark:/1303...
    Last time updated on 25/12/2021